ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS

Antiandrogen Monotherapy Market, by Type (Steroidal (Cyproterone Acetate), and Nonsteroidal (Bicalutamide and Flutamide)), by Disease Indication (Prostate Cancer, Benign Prostatic Hyperplasia, Hirsutism, Hyperandrogenism, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI3810
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Antiandrogen Monotherapy Market - Competitive Landscape

Key players operating in the global antiandrogen monotherapy market include Pfizer Inc., Astellas Pharma Inc., F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Abbott Laboratories, Takeda Pharmaceutical Company Limited, OSI Pharmaceuticals, Inc., Genentech Inc., Bristol-Myers Squibb Company, Novartis AG, Progenics Pharmaceuticals, Inc., ALZA Corporation, Sanofi SA, GlaxoSmithKline Plc, Amgen Inc, ANI Pharmaceuticals, Inc., and others.